Universe Pharmaceuticals INC (UPC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:06PM EST. Market open.
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 49.59M |
| Enterprise value 3 | 16.34M |
| Trailing P/E | 5.15 |
| Forward P/E 1 | N/A |
| PEG ratio (5-yr expected) 1 | N/A |
| Price/sales (ttm) | 1.28 |
| Price/book (mrq) | 0.98 |
| Enterprise value/revenue 3 | 0.42 |
| Enterprise value/EBITDA 7 | 1.19 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -54.53% |
| S&P500 52-week change 3 | 24.47% |
| 52-week high 3 | 11.9900 |
| 52-week low 3 | 2.1000 |
| 50-day moving average 3 | 2.3530 |
| 200-day moving average 3 | 2.9117 |
Share statistics
| Avg vol (3-month) 3 | 188.37k |
| Avg vol (10-day) 3 | 147.07k |
| Shares outstanding 5 | 21.75M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 7.08M |
| % held by insiders 1 | 67.46% |
| % held by institutions 1 | 1.61% |
| Shares short (14 Nov 2021) 4 | 38.77k |
| Short ratio (14 Nov 2021) 4 | 0.31 |
| Short % of float (14 Nov 2021) 4 | 0.42% |
| Short % of shares outstanding (14 Nov 2021) 4 | 0.18% |
| Shares short (prior month 14 Oct 2021) 4 | 38.76k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 29 Sept 2020 |
| Most-recent quarter (mrq) | 30 Mar 2021 |
Profitability
| Profit margin | 24.95% |
| Operating margin (ttm) | 34.33% |
Management effectiveness
| Return on assets (ttm) | 17.61% |
| Return on equity (ttm) | 28.26% |
Income statement
| Revenue (ttm) | 38.61M |
| Revenue per share (ttm) | 2.40 |
| Quarterly revenue growth (yoy) | 48.20% |
| Gross profit (ttm) | 14.09M |
| EBITDA | 13.7M |
| Net income avi to common (ttm) | 9.63M |
| Diluted EPS (ttm) | 0.5990 |
| Quarterly earnings growth (yoy) | 40.90% |
Balance sheet
| Total cash (mrq) | 36M |
| Total cash per share (mrq) | 1.65 |
| Total debt (mrq) | 2.75M |
| Total debt/equity (mrq) | 5.41 |
| Current ratio (mrq) | 3.73 |
| Book value per share (mrq) | 2.33 |
Cash flow statement
| Operating cash flow (ttm) | -1.21M |
| Levered free cash flow (ttm) | -645.13k |
© 2021 Yahoo. All rights reserved.
